Search the Newsreel

Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues

Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into Azenta, Inc. (AZTA) on behalf of investors who lost money. The investigation follows Azenta's Q2 2026 financial results, which missed consensus estimates and led to a significant stock price drop after …

Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP

Quantinno Capital Management LP significantly reduced its stake in Azenta, Inc. (NASDAQ:AZTA) by 63.3% in the first quarter, selling over 391,000 shares and retaining 226,690 shares valued at approximately $4.79 million. Despite this, Azenta recently surpassed quarterly earnings expectations, reporting an adjusted EPS of …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This follows Azenta's Q2 2026 financial results, which missed consensus estimates for EPS and revenue, reported a $149 million goodwill impairment, and led to a reduced …

Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA

Arrowstreet Capital Limited Partnership has acquired a new position in Azenta, Inc. (NASDAQ:AZTA), purchasing 71,410 shares valued at approximately $1.51 million, representing about 0.15% of the company. This comes as Azenta reported strong quarterly earnings, exceeding analyst estimates for both EPS and revenue, though …

Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary

Azenta, Inc. reported strong third-quarter 2026 results, with revenue increasing 12% year-over-year to $161.18 million and diluted EPS reaching $0.05, a significant improvement from a loss in the prior year. The company returned to a net income of $2.46 million, driven by growth in …

Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside

Azenta, Inc.'s stock price target has been increased from $27.8 to $33.8 by five analysts, implying a 12% potential upside based on its August 4th closing price. The consensus rating for the stock remains a "Buy" from six analysts. Investors can find more detailed …

Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed

Azenta (AZTA) Stock Rallies on Revenue Strength as Cash Burn Lingers

Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ...

Earnings call transcript: Azenta tops Q3 2026 estimates, shares edge higher

Azenta Q3 2026 EPS Tops Expectations, Revenue Up 12%

Azenta, Inc. reported strong Q3 2026 results, with Non-GAAP Diluted EPS of $0.16, significantly exceeding Wall Street's estimate of $0.12. The company's revenue rose 12.0% year-over-year to $161.2M, primarily driven by impressive organic growth of 9.0% and strong performance in its Sample Management Solutions …

Azenta, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:AZTA) 2026-08-05

Azenta, Inc. (AZTA) SVP acquires 335 shares via 2017 stock purchase plan

Ephraim Starr, SVP, General Counsel & Secretary of Azenta, Inc. (AZTA), purchased 335 shares of common stock on July 31, 2026, at $24.1676 per share through the company's 2017 Employee Stock Purchase Plan. This transaction, which was exempt from Section 16(b), increased his direct …

Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.16 per Share

Azenta, Inc. (AZTA) announced its Q3 adjusted EPS of $0.16 per share, surpassing FactSet's estimate of $0.11. The company also reported Q3 revenue of $161.2 million, exceeding FactSet's estimate of $149.3 million. This financial update indicates a stronger performance than anticipated by analysts for …

Azenta reports Q3 fiscal 2026: Revenue $161M, Adjusted EBITDA $18.5M, Non-GAAP EPS $0.16

Azenta (AZTA) reported its fiscal Q3 2026 results with revenue of $161.2 million and non-GAAP diluted EPS of $0.16. The company achieved an adjusted EBITDA of $18.5 million, representing an 11.4% margin, and noted 9% organic revenue growth year over year. Azenta also reiterated …

Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.

Azenta, Inc. reported its third-quarter financial results for fiscal year 2026, exceeding expectations with continued strength in recurring revenue and a modest improvement in Multiomics in North America. The company's revenue from continuing operations was $161 million, an increase of 12% year-over-year, and it …

Azenta earnings on deck: Can life sciences firm return to profit?

Azenta Inc. is scheduled to report its fiscal third-quarter earnings, with analysts expecting a return to profitability at $0.10 per share on $149.29 million in revenue, a significant improvement from the previous quarter's loss. Investors will be closely watching for sustained profitability, North American …

The Bull Case For Azenta (AZTA) Could Change Following Its Latest Earnings And Revenue Turnaround - Learn Why

Azenta earnings beat by $0.06, revenue topped estimates

Azenta (NASDAQ:AZTA) Issues Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Earnings Flash (AZTA) Azenta, Inc. Reports Q3 Revenue $161.2M, vs. FactSet Est of $149.3M

Azenta, Inc. (AZTA) reported its Q3 revenue at $161.2 million, surpassing FactSet's estimate of $149.3 million. This financial news highlights a stronger-than-anticipated performance for the biotechnology and medical research company in its third fiscal quarter. The report also mentions other recent financial updates for …

Azenta (AZTA) Reports Q2: Everything You Need To Know Ahead Of Earnings

Azenta (NASDAQ: AZTA), a life sciences company, is set to report its Q2 earnings this Tuesday. The company missed revenue expectations last quarter, reporting $144.8 million, and analysts are now forecasting a 3.7% year-over-year revenue growth. Investors will be watching closely to see if …

Azenta Inc (AZTA) Financial Health: Profitability & Balance Sheet Analysis

Azenta Inc (AZTA) currently holds a financial score of 8.14, placing it in the top 60 of 384 companies in the Biotechnology & Medical Research industry, indicating robust financial health and high operating efficiency. The company recently reported a quarterly revenue of $144.79 million, …

Azenta Inc (AZTA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Azenta Inc (AZTA), focusing on its P/E ratio and overall valuation score. Azenta's current valuation score is 8.18, placing it 160th out of 384 companies in the Biotechnology & Medical Research industry. The company's P/E ratio is …

Azenta Number of Employees 2026 | Employee Count & Headcount Data

Azenta, Inc. (AZTA) had approximately 3,042 total employees worldwide as of March 2026, representing a 6.4% decline from 2023. The company is actively hiring, though job postings decreased by 31.6% in 2026 compared to 2025. The workforce is primarily concentrated in the United States, …

Azenta Inc (AZTA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Azenta Inc (AZTA), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. While the stock currently trades between a resistance level of $30.57 and a support level …

Azenta (AZTA) Projected to Release Earnings on Tuesday

AZTA|Azenta Inc|Price:27.520|Chg%:+0.150

Azenta Inc. (AZTA) is a provider of life sciences solutions, specializing in cold-chain sample management and multiomics services for drug development, clinical research, and advanced cell therapies. The article details the company's business segments, key brands, financial data, and lists its executive team and …

Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Azenta Inc (AZTA), detailing its current earnings forecast score, average price target, and analyst ratings. It indicates that the company's expected revenue for the next quarter is $149.29 million, with analysts largely recommending a "Buy" for the …

Azenta, Inc. Revenue Breakdown – NASDAQ:AZTA

Azenta, Inc. (NASDAQ: AZTA) generated $593.82 million in revenue last year. The Sample Management Solutions segment was the top performer, contributing $324.59 million. The United States was the greatest regional contributor, accounting for $365.00 million.

Azenta, Inc. Revenue Breakdown – LSE:0HQ1

Azenta, Inc. (LSE:0HQ1) generated a total revenue of $593.82 million USD last year. The Sample Management Solutions segment was the top-performing segment, contributing $324.59 million USD, while the United States was the largest regional contributor with $365.00 million USD in revenue.

Robotics firm Brooks Automation weighs IPO - Bloomberg By Investing.com

Brooks Automation, a robotics and software automation company, is reportedly considering an initial public offering. The company, backed by Thomas H. Lee Partners, was formed after a $3 billion carve-out from the former Brooks Automation, with its life sciences arm renamed Azenta Inc. Deliberations …

Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast

Azenta, Inc. (NASDAQ: AZTA) will host a conference call and webcast on August 6, 2026, to discuss its financial results for the third quarter of fiscal year 2026. The company intends to issue a press release detailing these results after the market closes on …